SCHEMBL5174403

SCHEMBL5174403

CCCN(CCC)c1ccc(C#N)c(C(F)(F)F)c1.N#Cc1ccc(F)cc1C(F)(F)F

nearest known ligand 0.53

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
AR P10275 20/20 0.53
PGR P06401 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3051185 0.93 AR (0.59) ARPGR
SCHEMBL5175526 0.89 AR (0.48) ARPGR
SCHEMBL3055625 0.88 AR (0.54) ARPGR
SCHEMBL4901626 0.86 AR (0.53) ARPGR
SCHEMBL3048333 0.85 AR (0.54) ARPGR
SCHEMBL3054808 0.85 AR (0.57) ARPGR
SCHEMBL5692130 0.84 AR (0.51) ARPGR
SCHEMBL3050476 0.84 AR (0.51) ARPGR
SCHEMBL3047202 0.84 AR (0.53) ARPGR
SCHEMBL3416913 0.82 AR (0.49) ARPGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1747193-A1 BENZONITRILE DERIVATIVES TO TREAT MUSCULOSKELETAL FRAILTY Pfizer Products Incorporated (US) 2007-01-31 EP disclosed
WO-2005108351-A1 BENZONITRILE DERIVATIVES TO TREAT MUSCULOSKELETAL FRAILTY PFIZER PRODUCTS INC. (US) 2005-11-17 WO disclosed